Volume 40, Issue 1 p. 19-22
Clinical Investigation

PTCA in the Elderly: The “Young-Old” versus the “Old-Old”

Daniel E. Forman MDAaron D. Berman MDCarolyn H. McCabe BSDonald S. Baim MDJeanne Y. Wei MD, PhD

Corresponding Author

Jeanne Y. Wei MD, PhD

Address reprint requests to Jeanne Y. Wei, MD, Beth Israel Hospital, Department of Medicine, 330 Brookline Avenue, Boston, MA 02215.Search for more papers by this author
First published: January 1992
Citations: 134
From the Charles A. Dana Research Institute and the Harvard-Thorndike Laboratory of Beth Israel Hospital, Department of Medicine, Beth Israel Hospital and Harvard Medical School, Geriatric Research Education and Clinical Center, West Roxbury/Brockton VA Medical Center, Boston, Massachusetts.
Presented at American Geriatrics Society Plenary Session, Atlanta, Georgia, May, 1990.

Abstract

Objective

To evaluate the use of percutaneous transluminal coronary angioplasty (PTCA) in elderly coronary artery disease (CAD) patients.

Design

A prospective study of patients 60 years and older undergoing de novo PTCA. We analyze patient risk factors, underlying disease, and clinical outcomes, with at least 3-year follow-up. Comparisons between different age strata among these patients are made to clarify differences between the young old (60 to 69 years), the middle old (70 to 79 years), and the very old (80 years and older).

Setting

Beth Israel Hospital, Boston, both a primary care and tertiary care teaching hospital.

Patients

907 consecutive elderly cardiac patients referred for PTCA are studied.

Interventions

PTCA's were completed using the newest catheter technologies as they became available. All patients were premedicated with aspirin and dipyridamole, and all were anticoagulated with heparin.

Results

Subdivision by age demonstrates that the majority (67%) of patients aged 60 to 69 were males, but females were preponderant (61%) in those aged 80 and older. Octogenarians also had lower incidence of hypercholesterolemia, tobacco use, and family history of CAD, and a higher frequency of CHF, angina, and previous MI. Although total procedure-complications increased with age, critical complications (MI, reocclusion, CABG, death) did not. Primary procedural success was similar in all age strata, but older patients had a higher prevalence of multi-vessel disease and longer hospital stay. Follow-up shows that most patients did well after PTCA; there was no increase in repeat PTCA, CABG, and MI with age.

Conclusions

While advanced age is associated with changes in risk and clinical parameters for CAD patients, age alone is not a reasonable criterion to limit the use of PTCA.